Published 5 September 2026. Last reviewed 9 September 2026.
Because L-ascorbic acid crosses the stratum corneum only when it is un-ionised, and that requires formulating below pH 3.5. Above that threshold the molecule ionises, the lipid barrier excludes it, and the concentration printed on the label stops predicting how much vitamin C actually reaches the tissue.
Where the threshold comes from
The figure is not a rule inherited from the industry: it comes from a percutaneous absorption study published by Pinnell and colleagues in 2001. The authors applied L-ascorbic acid and several derivatives to porcine skin and measured the resulting cutaneous levels. The design is simple, which is why the result is robust: what is measured is what goes in, not what is applied.
Three parameters derive from that work, and they still define the formulation of topical vitamin C.
1. The pH threshold
L-ascorbic acid penetrates skin only when the formulation sits below pH 3.5. The reason is elementary chemistry: at higher pH the molecule is predominantly in its ionised, charged form, and a barrier of lipid nature does not readily admit charged species.
2. The concentration ceiling
Optimal percutaneous absorption was reached at a concentration of 20%. Going above that did not increase the amount deposited in tissue. It is a finding with awkward commercial consequences: a concentration above 20% is not, on its own, an argument for greater efficacy.
3. The saturation kinetics
Tissue levels saturated after three consecutive daily applications, and the half-life of disappearance from tissue was approximately four days. The practical reading is twofold: the effect of a regimen is not judged on day one, and once saturation is reached the cutaneous reservoir declines slowly.
The derivatives that were tested
The same study evaluated three ascorbic acid derivatives - magnesium ascorbyl phosphate, ascorbyl-6-palmitate and dehydroascorbic acid - and none of them increased cutaneous levels of L-ascorbic acid. The scope of that result deserves precision, because it is usually cited more broadly than it permits: it refers to those three compounds under those experimental conditions, not to any ascorbyl ester whatsoever.
What is gained, and what is traded, by turning to lipid-soluble esters
The pH constraint explains why the dermocosmetic industry turned towards lipid-soluble ascorbate esters, which are formulated without that condition. The trade is not free, however: lipophilic derivatives are not vitamin C but precursors that require in vivo conversion to release active ascorbic acid.
A second condition is documented for tetrahexyldecyl ascorbate: under singlet oxygen the ester degraded completely within six minutes unless accompanied by a stabilising antioxidant. Independence from pH therefore solves the problem of entry, not the problem of persistence.
What actually determines entry
| Factor | Documented effect |
|---|---|
| Formulation pH | Decisive. Above 3.5 there is no appreciable penetration of L-ascorbic acid |
| Concentration | Decisive up to 20%; above that, no measured gain |
| Number of applications | Tissue saturation at three daily applications |
| Persistence | Tissue half-life of about four days |
| Chemical form | The derivatives tested in 2001 did not raise cutaneous L-ascorbic acid levels |
Definitions
Stratum corneum. The outermost layer of the epidermis, made of corneocytes embedded in a lipid matrix. It is the barrier that determines which molecules can cross the skin and which cannot.
Ionisation. The state in which a molecule carries a net electrical charge. It depends on the pH of the medium and on the compound's dissociation constant. Charged species cross lipid barriers with difficulty.
Tissue half-life. The time needed for the concentration of a substance in tissue to fall by half once application ceases.
Full technical report
The evidence summarised here is set out in full, with methods, tables and limitations, in our open-access technical report, deposited with a permanent DOI: TTS Clinical Scientific Team (2026). Topical Vitamin C: the pH Constraint on L-Ascorbic Acid and the Oxidative Stability of Tetrahexyldecyl Ascorbate, version 1.0. https://doi.org/10.5281/zenodo.22491021 (CC BY 4.0).
References
- Pinnell, S. R., Yang, H., Omar, M., Monteiro-Riviere, N., DeBuys, H. V., Walker, L. C., Wang, Y., Levine, M. (2001). Topical L-ascorbic acid: percutaneous absorption studies. Dermatologic Surgery, 27(2), 137-142. DOI: 10.1046/j.1524-4725.2001.00264.x · PMID 11207686
- Swindell, W. R., Randhawa, M., Quijas, G., Bojanowski, K., Chaudhuri, R. K. (2021). Tetrahexyldecyl Ascorbate (THDC) Degrades Rapidly under Oxidative Stress but Can Be Stabilized by Acetyl Zingerone to Enhance Collagen Production and Antioxidant Effects. International Journal of Molecular Sciences, 22(16), 8756. DOI: 10.3390/ijms22168756 · PMID 34445461
- Yin, X., Chen, K., Cheng, H., Chen, X., Feng, S., Song, Y., Liang, L. (2022). Chemical Stability of Ascorbic Acid Integrated into Commercial Products: A Review on Bioactivity and Delivery Technology. Antioxidants, 11(1), 153. DOI: 10.3390/antiox11010153
This article describes published findings on formulation chemistry. It does not constitute a product claim and does not describe the treatment, prevention or mitigation of any condition.